Improving time to optimal Staphylococcus aureus treatment using a penicillin-binding protein 2a assay

References

1. Alere( 2016;). PBP2a culture colony test. . http://www.alere.com/en/home/product-details/pbp2a.html. Accessed 7.31.2016.
2. Bauer K. A., West J. E., Balada-Llasat J. M., Pancholi P., Stevenson K. B., Goff D. A..( 2010;). An antimicrobial stewardship program's impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus/S. aureus blood culture test in patients with S. aureus bacteremia. . Clin Infect Dis51:1074––1080. [CrossRef][PubMed]
   [Google Scholar]
3. Bauer K. A., Perez K. K., Forrest G. N., Goff D. A..( 2014;). Review of rapid diagnostic tests used by antimicrobial stewardship programs. . Clin Infect Dis59:S134––S145. [CrossRef][PubMed]
   [Google Scholar]
4. Brown J., Paladino J. A..( 2010;). Impact of rapid methicillin-resistant Staphylococcus aureus polymerase chain reaction testing on mortality and cost effectiveness in hospitalized patients with bacteraemia: a decision model. . Pharmacoeconomics28:567––575. [CrossRef][PubMed]
   [Google Scholar]
5. CDC( 2014;). The Center for Disease Control and Prevention: Core Elements of Hospital Antibiotic Stewardship Programs. . http://www.cdc.gov/getsmart/healthcare/implementation/core-elements.html. Accessed 7.31.2016.
6. CLSI( 2016;). Performance Standards for Antimicrobial Susceptibility Testing; , twenty-sixth informational supplement. CLSI document M100-S26., Wayne, PA:: Clinical and Laboratory Standards Institute;.
   [Google Scholar]
7. Cosgrove S. E., Sakoulas G., Perencevich E. N., Schwaber M. J., Karchmer A. W., Carmeli Y..( 2003;). Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. . Clin Infect Dis36:53––59. [CrossRef][PubMed]
   [Google Scholar]
8. Forrest G. N., Mehta S., Weekes E., Lincalis D. P., Johnson J. K., Venezia R. A..( 2006;). Impact of rapid in situ hybridization testing on coagulase-negative staphylococci positive blood cultures. . J Antimicrob Chemother58:154––158. [CrossRef][PubMed]
   [Google Scholar]
9. Mosammaparast N., McAdam A. J., Nolte F. S..( 2012;). Molecular testing for infectious diseases should be done in the clinical microbiology laboratory. . J Clin Microbiol50:1836––1840. [CrossRef][PubMed]
   [Google Scholar]
10. Newcombe R. G..( 1998;). Two-sided confidence intervals for the single proportion: comparison of seven methods. . Stat Med17:857––872. [CrossRef][PubMed]
    [Google Scholar]
11. Nicolsen N. C., LeCroy N., Lecroy N., Alby K., Martin K. E., Laux J., Lin F. C., Daniels L., Weber D. J., Miller M. B..( 2013;). Clinical outcomes with rapid detection of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates from routine blood cultures. . J Clin Microbiol51:4126––4129. [CrossRef][PubMed]
    [Google Scholar]
12. Schweizer M. L., Furuno J. P., Harris A. D., Johnson J. K., Shardell M. D., McGregor J. C., Thom K. A., Cosgrove S. E., Sakoulas G., Perencevich E. N..( 2011;). Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia. . BMC Infect Dis11:279––285. [CrossRef][PubMed]
    [Google Scholar]
13. TJC( 2013;). The Joint Commission: Antimicrobial Stewardship Toolkit SKU# FR1007. . http://www.jcrinc.com/antimicrobial-stewardship-toolkit/. Accessed on 31 July 2016.
14. TJC( 2016;). The Joint Commission: Joint Commission unveils new antimicrobial stewardship standard. . https://www.jointcommission.org/issues/article.aspx?Article=8/edJxSI/ROgKZhv46xb1vQ5282rP1aYDfaGA3GiMJM%3D. Accessed on 31 July 2016.